News Select Year All Years 2025 (35) 2024 (31) 2023 (31) 2022 (35) 2021 (28) 2020 (36) 2019 (46) 2018 (51) 2017 (34) 2016 (26) 2015 (42) 2014 (30) 2013 (26) 2012 (23) 2011 (28) 2010 (36) 2009 (39) 2008 (55) 2007 (50) Clinical Trials Select Clinical Trial AWARE-1 (20) BRACELET-1 (10) GOBLET (32) Search … June 1, 2017 Oncolytics Biotech® Announces Closing of Public Offering of Units May 24, 2017 Oncolytics Biotech® Prices Public Offering of Units May 23, 2017 Oncolytics Biotech® Inc. Announces Participation in World Immunotherapy Congress USA 2017 May 23, 2017 Oncolytics Biotech® Announces Proposed Public Offering May 17, 2017 Oncolytics Biotech® Announces ASCO Abstracts and Preliminary Data for Studies in Pancreatic and Prostate Cancers May 8, 2017 Oncolytics Biotech® Inc. Announces FDA Fast Track Designation for REOLYSIN® in Metastatic Breast Cancer May 5, 2017 Oncolytics Biotech® Inc. Announces 2017 First Quarter Results May 4, 2017 Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders April 27, 2017 Oncolytics Biotech® Inc. Announces Details of 2017 Annual Meeting of Shareholders April 26, 2017 Oncolytics Biotech® Inc. to Present at the Sixth Annual Bloom Burton & Co. Healthcare Investor Conference Newer Page 32 of 69 Older